Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Chubb
Citi
Teva
Baxter
Queensland Health
Mallinckrodt
Novartis
Cantor Fitzgerald
Dow

Generated: August 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075241

« Back to Dashboard
NDA 075241 describes FUROSEMIDE, which is a drug marketed by Sun Pharm Inds, Fresenius Kabi Usa, Watson Labs, Abraxis Pharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Astrazeneca, Dava Pharms Inc, Accord Hlthcare, Marsam Pharms Llc, Warner Chilcott, Smith And Nephew, West-ward Pharms Int, Intl Medication, Emcure Pharms Ltd, Watson Labs Teva, Hospira, Wockhardt, Claris, Sandoz, Amneal Pharms Co, Sun Pharm Inds Inc, Kalapharm, Wyeth Ayerst, Superpharm, Luitpold, Mylan, Mutual Pharm, Leading Pharma Llc, Igi Labs Inc, and Prinston Inc, and is included in fifty-seven NDAs. It is available from sixty suppliers. Additional details are available on the FUROSEMIDE profile page.

The generic ingredient in FUROSEMIDE is furosemide. There are twenty-one drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the furosemide profile page.

Summary for NDA: 075241

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 075241

Suppliers and Packaging for NDA: 075241

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FUROSEMIDE
furosemide
INJECTABLE;INJECTION 075241 ANDA Hospira, Inc. 0409-1639 0409-1639-10 10 CARTON in 1 PACKAGE (0409-1639-10) > 1 SYRINGE, PLASTIC in 1 CARTON (0409-1639-21) > 10 mL in 1 SYRINGE, PLASTIC
FUROSEMIDE
furosemide
INJECTABLE;INJECTION 075241 ANDA Hospira, Inc. 0409-9631 0409-9631-04 10 CARTON in 1 PACKAGE (0409-9631-04) > 1 SYRINGE, PLASTIC in 1 CARTON (0409-9631-14) > 4 mL in 1 SYRINGE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:May 28, 1999TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
McKinsey
Citi
Harvard Business School
Cantor Fitzgerald
Cerilliant
Covington
QuintilesIMS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot